𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pathology of borderline HER-2/neu breast carcinoma: a biologically distinct phenotype

✍ Scribed by Jeffrey L. Killeen; Anna Ortega-Lopez; James Shaha; Steven H. Shaha; Jennifer B. Fu

Publisher
Springer US
Year
2006
Tongue
English
Weight
331 KB
Volume
98
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A comparison of five immunohistochemical
A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma
✍ Doo Ho Choi; Dong Bok Shin; Min Hyuk Lee; Dong Wha Lee; Devika Dhandapani; Darry πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objective of this article was to compare five tumor markers between white women in the U.S. and native Korean women with early‐onset breast carcinoma. ## METHODS Sixty Korean women who were diagnosed with breast carcinoma at age 45 years or younger and 60 white wome

Decreased immunoreactivity for p27 prote
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V
✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m